Synthesis, Crystal Structure and Catalytic Activity of Tri-Nuclear Zn(II) Complex Based on 6-Phenylpyridine-2-carboxylic Acid and Bis(4-pyridyl)amine Ligands

A new trinuclear Zn (II) complex, [Zn3(L1)4(L2)2(CH3COO)2] (1) (HL1 = 6-phenylpyridine-2-carboxylic acid, L2 = bis(4-pyridyl)amine) has been synthesized by 6-phenylpyridine-2-carboxylic acid, NaOH, bis(4-pyridyl)amine and Zn(CH3COO)2•2H2O. The complex 1 has also been structural characterized by elemental analysis and single crystal X-ray diffraction. The results reveals that complex 1 is made up of three Zn(II) ions, four L1 ligands, two L2 ligands and two CH3COO- anions. In 1, both Zn1 ion and Zn1a ion are five-coordinated with two O atoms from two different L1 ligands, two N atoms from two different L1 ligands, and one N atoms from bis(4-pyridyl)amine ligand, respectively, and forms a distorted trigonal biyramid geometry. And Zn2 ion is four-coordinated with two O atoms from two different CH3COO− anions and two N atoms from two different L2 ligands, forming a distorted tetrahedral geometry. Complex 1 displays a 3D network structure by the intermolecular N−H···O hydrogen bonds. The catalytic performance for oxidation of benzyl alcohol with O2 was studied under mild reaction conditions using complex 1 as catalyst. The results demonstrated that the catalysts were very active, and the yield of benzaldehyde was 50.8% at 90 °C with THF as solvent under 0.5 MPa O2 within 3 h. Copyright © 2022 by Authors, Published by BCREC Group. This is an open access article under the CC BY-SA License (https://creativecommons.org/licenses/by-sa/4.0). 

The crystal structure of [(1,10-phenantroline-κ2 N,N′)-bis(6-phenylpyridine-2-carboxylato-κ2 N,O)manganese(II)] monohydrate, C36H26N4O5Mn

C36H26N4O5Mn, orthorhombic, P212121 (no. 19), a = 10.7134(7) Å, b = 10.7573(10) Å, c = 26.6304(18) Å, β = 90°, V = 3069.1(4) Å3, Z = 4, R gt (F) = 0.0454, wR ref (F 2) = 0.0890, T = 220 K.

The crystal structure of poly[μ2-aqua- aqua-(μ3-(E)-2-(4-((2-carbamothioylhydrazineylidene)methyl)phenoxy)acetato-κ3 O:S:S)sodium(I)], C10H14N3O5SNa

C10H14N3O5SNa, triclinic, P 1 ‾ $P\overline{1}$ (no. 2), a = 6.7015(5) Å, b = 7.5656(5) Å, c = 14.1332(8) Å, β = 93.159(5)°, V = 654.71(8) Å3, Z = 2, R gt (F) = 0.0357, wR ref (F 2) = 0.0872, T = 273 K.

The crystal structure of [(phenantroline-κ2 N,N′)-bis(6-phenylpyridine-2-carboxylate-κ2 N,O)cobalt(II)]monohydrate, C36H26N4O5Co

C36H26N4O5Co, triclinic, P212121 (no. 19), a = 10.6380(5) Å, b = 10.6639(5) Å, c = 26.5443(15) Å, V = 3011.2(3) Å3, Z = 4, R gt (F) = 0.0330, wR ref (F 2) = 0.0681, T = 200 K.